Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - LIGAND PHARMACEUTICALS INC | a10-kaexhibit321.htm |
| EX-31.2 - EXHIBIT 31.2 - LIGAND PHARMACEUTICALS INC | a10-kaexhibit312.htm |
| EX-31.1 - EXHIBIT 31.1 - LIGAND PHARMACEUTICALS INC | a10-kafexhibit311.htm |
| EX-23.1 - EXHIBIT 23.1 - LIGAND PHARMACEUTICALS INC | a10-kaexhibit231.htm |
| 10-K/A - 10-K/A - LIGAND PHARMACEUTICALS INC | a10-kaforlgndx20151231x10k.htm |
Exhibit 21.1
LIGAND PHARMACEUTICALS INCORPORATED
LIST OF SUBSIDIARIES
Name | Jurisdiction of Incorporation | |
Glycomed Incorporated | California | |
Allergan Ligand Retinoid Therapeutics, Inc. | Delaware | |
Ligand Pharmaceuticals International, Inc. | Delaware | |
Ligand Biopharmaceuticals, Incorporated | Delaware | |
Ligand JVR, Inc. | Delaware | |
Seragen Incorporated | Delaware | |
Seragen Technology, Inc. | Delaware | |
Pharmacopeia, LLC | Delaware | |
Metabasis Therapeutics, Inc. | Delaware | |
Neurogen Corporation | Delaware | |
CyDex Pharmaceuticals, Inc. | Delaware | |
Open Monoclonal Technology, Inc. | Delaware | |
OMT I, Inc. | Delaware | |
OMT I, Inc. | Delaware | |